Newer drugs are more targeted than standard agents, but their incorporation into treatment regimens is challenging because of the risk of cardiovascular and infectious adverse events.
If not properly monitored and treated, this adverse event can manifest into torsades de pointes, leading to sudden cardiac death.
Awareness of a patient’s potential procedures and changes in nutritional intake enables the pharmacist to prevent hypoglycemic events by proactively adjusting the insulin regimen.